Jan-Feb 2023 Digital Forum
In this issue, Board President Michaux R. Kilpatrick, MD, PhD, discusses how NCMB is working on ways to help licensees keep patient welfare their top priority in an increasingly corporate health care environment, we review the recent dissolution of the X-Waiver program for buprenorphine prescribers and we highlight the licensee’s duty to report professional sexual misconduct by others to NCMB in our latest podcast episode. Also find public Board Actions for Nov-Dec 2022 and a reminder to check your email - are you missing messages from NCMB?
Articles
- From the President: Keeping patient welfare ahead of corporate interests | by Michaux R. Kilpatrick, MD, PhD
- Nov-Dec 2022 Board Actions Report
- Reminder: NCMB uses email, not snail mail
- Prescribing medication for addiction treatment: now with no waivers and no limits
- New on the podcast: the licensee’s duty to report sexual misconduct to NCMB
- New case-based feature starts strong
- All APP QI meeting requirements back in place
